Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202500496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hui Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong University, Jinan, P. R. China. Hauptthemen laut MEDLINE: Physalis, Anti-Inflammatory Agents, Asthma, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Chinese medicine in National Administration of Traditional Chinese Medicine, Major Scientific and Technological Innovation Projects of Shandong Key R & D Plan.
Abstract (Originalsprache)
Physalis Calyx seu Fructus (PCF) is frequently prescribed for treating inflammation‐related respiratory diseases in traditional Chinese medicine. The aim of the study is to identify the active partitions of PCF against inflammation‐related respiratory diseases and explore their therapeutic effects and mechanisms. In the present study, two active partitions, 50‐EFP‐2 and 70‐EFP, were obtained through anti‐inflammatory bioactivity‐guided enrichment of macroporous resin. These two partitions at 10 mg/kg potently alleviated lipopolysaccharide (LPS)‐stimulated acute lung inflammation (ALI) and ovalbumin (OVA)‐induced asthma in mice. Phytochemical investigation was performed using ultra‐performance liquid chromatography‐tandem mass spectrometry (UPLC‐MS/MS) and high‐performance LC (HPLC), and indicated that withanolides are the predominant constituents of these two partitions. Moreover, their potential targets were predicted by network pharmacological analysis, which showed that withanolides in PCF mainly attenuated ALI and asthma by regulating nuclear factor‐κB (NF‐κB) to inhibit inflammatory response. 50‐EFP‐2 and 70‐EFP inhibited inflammation and oxidative stress by regulating NF‐κB and nuclear factor erythroid 2‐related factor 2 (Nrf2), both in vivo and in vitro. Collectively, two partitions rich in withanolides were discovered from PCF, which potently alleviated ALI and asthma by regulating Nrf2 and NF‐κB pathways. These findings provide the foundation for discovering withanolide‐type leading compounds and developing novel therapeutics against inflammation‐related respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong University, Jinan, P. R. China.
- Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, P. R. China.
- Shandong Engineering Research Center for Traditional Chinese Medicine Standard, School of Pharmaceutical Sciences, Shandong University, Jinan, P. R. China.
- Shandong Institute for Food and Drug Control, Jinan, P. R. China.
- Department of Pharmacy, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, P. R. China.
ORCID-Profile: Tao Shen
Förderung
- National Natural Science Foundation of China
- Chinese medicine in National Administration of Traditional Chinese Medicine
- Major Scientific and Technological Innovation Projects of Shandong Key R & D Plan
- Shandong Provincial Natural Science Foundation
- Key R&D Program of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Meng, H., Xu, L. T., Li, P. P., Guo, D. X., Li, G. H., Gu, H. R., Wang, X. N., Lin, Y. Q., Xu, Z. P., & Shen, T. (2026). Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500496
Vancouver
Meng H, Xu LT, Li PP, Guo DX, Li GH, Gu HR, et al. Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202500496
BibTeX
@article{Meng2026,
author = {Meng, Hui and Xu, Lin-Tao and Li, Ping-Ping and Guo, Dong-Xiao and Li, Guo-Hui and Gu, Hao-Ran and Wang, Xiao-Ning and Lin, Yong-Qiang and Xu, Zhen-Peng and Shen, Tao},
title = {Exploring the Active Substances and Mechanism of Physalis Calyx seu Fructus Against Inflammation‐related Respiratory Diseases via Integrating Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry, Network Pharmacological Analysis, and Experimental Verification},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202500496}
}
EUVIMED